Suppr超能文献

晚期肝病患者的重症监护治疗

Intensive Care Therapy for Patients with Advanced Liver Diseases.

作者信息

Katsounas Antonios, Canbay Ali

机构信息

Department for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Magdeburg, Magdeburg, Germany.

出版信息

Visc Med. 2018 Aug;34(4):283-289. doi: 10.1159/000492088. Epub 2018 Aug 8.

Abstract

Decompensated cirrhosis is characterized by high hospitalization rates and costs, frequent readmissions, and poor short-term survival. Patients admitted to the hospital with acute variceal bleeding and/or hepatic encephalopathy and/or renal dysfunction are at serious risk for developing infection and/or sepsis; in turn, this renders them highly susceptible to the development of multi-system organ failure. The lack of standardized intensive care unit management protocols in patients with cirrhosis along with only few data reports from longitudinal clinical trials makes it difficult for hepatologists and critical care specialists to provide uniform evidence for clinical practice that could safely consolidate favorable outcomes such as lower hospitalization rates and/or mortality. Based on a rigorous online search of the scientific literature as well as a longtime clinical experience of the authors in the field of hepatology and critical care medicine, this work represents a focused effort to elucidate the specific bio-morbidity of advanced liver diseases in relation to the aforementioned challenges in clinical management. Further meta-analyses and/or systematic reviews are needed to enable clinicians to develop more effective strategies to bridge patients with decompensated liver disease to recompensation or liver transplantation.

摘要

失代偿期肝硬化的特点是住院率高、费用高、频繁再入院以及短期生存率低。因急性静脉曲张出血和/或肝性脑病和/或肾功能不全入院的患者发生感染和/或脓毒症的风险很高;反过来,这使他们极易发生多系统器官衰竭。肝硬化患者缺乏标准化的重症监护病房管理方案,同时纵向临床试验的数据报告很少,这使得肝病学家和重症监护专家难以提供统一的临床实践证据,以安全巩固诸如降低住院率和/或死亡率等良好结果。基于对科学文献的严格在线搜索以及作者在肝病学和重症医学领域的长期临床经验,这项工作旨在集中阐明晚期肝病的特定生物发病率与上述临床管理挑战之间的关系。需要进一步的荟萃分析和/或系统评价,以使临床医生能够制定更有效的策略,将失代偿性肝病患者过渡到代偿或肝移植。

相似文献

1
Intensive Care Therapy for Patients with Advanced Liver Diseases.晚期肝病患者的重症监护治疗
Visc Med. 2018 Aug;34(4):283-289. doi: 10.1159/000492088. Epub 2018 Aug 8.
9
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.

引用本文的文献

1
[When should a liver disease patient be admitted to the intensive care unit?].[肝病患者何时应入住重症监护病房?]
Med Klin Intensivmed Notfmed. 2024 Sep;119(6):470-477. doi: 10.1007/s00063-024-01160-w. Epub 2024 Jul 17.
5
7
Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis.肝硬化中的免疫功能障碍和白蛋白相关免疫。
Mediators Inflamm. 2019 Feb 25;2019:7537649. doi: 10.1155/2019/7537649. eCollection 2019.
8
Acute-on-Chronic Liver Failure.慢加急性肝衰竭
Visc Med. 2018 Aug;34(4):243-244. doi: 10.1159/000492588. Epub 2018 Aug 17.

本文引用的文献

1
Immunodysfunction in Acute-on-Chronic Liver Failure.慢加急性肝衰竭中的免疫功能障碍
Visc Med. 2018 Aug;34(4):276-282. doi: 10.1159/000488690. Epub 2018 Jul 3.
7
Branched-chain amino acids for people with hepatic encephalopathy.用于肝性脑病患者的支链氨基酸
Cochrane Database Syst Rev. 2017 May 18;5(5):CD001939. doi: 10.1002/14651858.CD001939.pub4.
8
Probiotics for people with hepatic encephalopathy.用于肝性脑病患者的益生菌。
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD008716. doi: 10.1002/14651858.CD008716.pub3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验